Sounds equal to the fatality rate without it. Am I missing something?
RE: Sounds equal to the fatality rate without it. Am I missing something?
I think you’re missing the CONDITION of the patient before going on the HCQ+Azithromycn regiment.
Again, all studies, including Dr. Raoult’s show that:
1. It has to be applied as soon as: a) The patient is CoVid-19 positive; and b) shows fever, coughing and/or breathing problems.
2. Do not wait till the lungs are so compromised and damaged by pneumonia and the patient needs a respirator.
If you do the above, all experience shows that the patient gets better with 6 days.
This significantly eases the burden of hospitals and healthcare workers and also reduces the death rate.
If you administer it when the patient is already on a respirator, the effectiveness goes down. The lungs could already be damaged. There’s still a chance the patient recovers as other cases show, but effectivity is not guaranteed.
Also, Zinc is a major component of the treatment.
What many doctors observe is that the virus uses the cell as a platform to replicate. Because this invader is new, the immune system overreacts (especially true for mature individuals like the elderly) and creates what is known as a Cytokine storm, sort of like a soldier shooting at everything in sight, not differentiating between the good and bad guys, thus, killing the good as well. This causes ARDS (Acute Respiratory Distress Syndrome), where fluid collects in the lungs and air sacs depriving oxygen.
Hydroxychloroquine acts as an ionosphere where Zinc can work to prevent the virus from replicating. Hydroxychloroquine also acts to modulate autoimmune response ( much like it does lupus ), so that the immune system’s cytokine storm calms down giving the body the chance to fight off the invader without killing its own healthy lung cells.
Azithromycin is used to fight possible bacterial infection.
IN SUM:
These 3: HCQ+AZITHROMYCIN+ZINC, given at the right doses EARLY before the disease has the chance to progress to a more severe state is what accounts for most of the success.
Dr. Didier’s latest study simply reinforces these.
If I interpret the data at https://www.mediterranee-infection.com/covid-19/ correctly, 0.5% is about one-third the mortality rate at two Marseille hospitals near Dr. Raoult's institute, for COVID-19 patients who did not receive HCQ-AZ.
Also, HCQ-AZ is said to reduce patient viral loads, which shortens the duration of illness and and reduces contagion. We'll have to wait for the full study to be published to get the details.
“Sounds equal to the fatality rate without it. Am I missing something?”
Yes, this...
“A recent study of COVID-19 cases in the United States estimated a mortality rate of 10% to 27% for those ages 85 and over, 3% to 11% for those ages 65 to 84, 1% to 3% for those ages 55 to 64 and less than 1% for those ages 20 to 54.”
From...https://www.livescience.com/is-coronavirus-deadly.html